After how many days after stopping fluoxetine should linezolid be started?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Washout Period for Fluoxetine Before Starting Linezolid

Wait at least 5 weeks after stopping fluoxetine before starting linezolid to prevent potentially fatal serotonin syndrome. 1

Rationale for the 5-Week Washout Period

The extended washout period is driven by fluoxetine's unique pharmacokinetic profile:

  • Fluoxetine has an exceptionally long elimination half-life of 4-6 days after chronic administration, and its active metabolite norfluoxetine has an even longer half-life of 4-16 days. 1

  • After chronic dosing, active drug substance persists in the body for weeks after discontinuation, primarily depending on individual patient characteristics, previous dosing regimen, and length of therapy. 1

  • The FDA drug label explicitly states that "at least 5 weeks (perhaps longer, especially if fluoxetine has been prescribed chronically and/or at higher doses) should be allowed after stopping Prozac before starting an MAOI." 1

Why This Matters: Serotonin Syndrome Risk

Linezolid is a reversible, nonselective monoamine oxidase inhibitor (MAOI) that can trigger serotonin syndrome when combined with serotonergic drugs like SSRIs. 2, 3

The clinical consequences are severe:

  • Serotonin syndrome presents with mental status changes (confusion, agitation, anxiety), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity), and autonomic hyperactivity (hypertension, tachycardia, arrhythmias, diaphoresis). 2

  • Advanced symptoms include fever, seizures, arrhythmias, and unconsciousness, which can lead to fatalities. 2

  • Symptoms can arise within 24 to 48 hours after combining medications. 2

Clinical Context and Caveats

While retrospective data suggest that only 2-3% of patients receiving linezolid with SSRIs develop serotonin syndrome 4, the FDA contraindication and drug label guidance must take precedence given the potentially fatal outcome.

Important considerations:

  • The 5-week washout applies specifically to fluoxetine due to its uniquely long half-life; other SSRIs with shorter half-lives (sertraline, citalopram, paroxetine) require only a 14-day washout before starting an MAOI. 1

  • If fluoxetine was prescribed chronically or at higher doses, consider waiting even longer than 5 weeks. 1

  • Linezolid should generally not be administered to patients taking any serotonergic agents because of the potential for serious CNS reactions. 3

  • If serotonin syndrome develops, treatment requires immediate discontinuation of all serotonergic agents, hospital-based supportive care, and continuous cardiac monitoring. 2

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

treatment of drug-resistant tuberculosis. an official ats/cdc/ers/idsa clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2019

Research

Linezolid and serotonergic drug interactions: a retrospective survey.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.